Literature DB >> 2568301

The guanylate cyclase/receptor family of proteins.

S Schulz1, M Chinkers, D L Garbers.   

Abstract

Guanylate cyclase, which catalyzes the formation of cGMP from GTP, exists in both the soluble and particulate fractions of cells. At least two different cellular compartments for the particulate enzyme exist: the plasma membrane and cytoskeleton. The enzyme form found in the soluble fraction is a heterodimer that can be regulated by free radicals and nitrovasodilators, whereas the membrane form exists as a single-chain polypeptide that can be regulated by various peptides. These peptides include resact and speract obtained from eggs and atrial natriuretic peptides (ANP). The species of guanylate cyclase present in cytoskeletal fractions resists solubilization with non-ionic detergents; its structural properties are not yet known. cDNAs encoding the membrane form of guanylate cyclase have been isolated from different tissues and species, and in all cases the DNA sequences predict a protein containing a single transmembrane domain. The carboxyl (intracellular) domain is highly conserved from sea urchins through mammals, whereas the extracellular domain (amino terminus) varies considerably. The predicted amino acid sequences demonstrate that the membrane form of guanylate cyclase is a member of a diverse and complex family of proteins that includes a low molecular weight ANP receptor, protein kinases, and the cytoplasmic form of guanylate cyclase. cDNA encoding a membrane form of the enzyme from mammalian tissues has been expressed in cultured cells, and the expressed guanylate cyclase specifically binds ANP and is activated by ANP. The membrane form of guanylate cyclase, then, serves as a cell surface receptor, representing the first recognized protein to directly catalyze formation of a low molecular weight second messenger in response to ligand binding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568301     DOI: 10.1096/fasebj.3.9.2568301

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  20 in total

Review 1.  Regulation of neuronal proliferation and differentiation by nitric oxide.

Authors:  Sarah M Gibbs
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 2.  Receptor guanylyl cyclases.

Authors:  S K Wong; D L Garbers
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Nucleotide regulation of heat-stable enterotoxin receptor binding and of guanylate cyclase activation.

Authors:  L C Katwa; C D Parker; J K Dybing; A A White
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  Fundamental role of nitric oxide in neuritogenesis of PC12h cells.

Authors:  Matsumi Yamazaki; Kenzo Chiba; Tetsuro Mohri
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

5.  Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes.

Authors:  T Tanke; J W van de Loo; H Rhim; P S Leventhal; R A Proctor; P J Bertics
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

6.  Volume status influences atrial peptide-induced water conductivity changes in leopard frog mesenteric capillaries.

Authors:  D J Meyer; V H Huxley; M K McKay
Journal:  J Physiol       Date:  1992-02       Impact factor: 5.182

7.  Characterization of guanylyl cyclase in purified myelin.

Authors:  M Grabow; G Chakraborty; R W Ledeen
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

8.  Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP.

Authors:  J Barsony; S J Marx
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.

Authors:  Eveline Boudin; Tjeerd R de Jong; Tim C R Prickett; Bruno Lapauw; Kaatje Toye; Viviane Van Hoof; Ilse Luyckx; Aline Verstraeten; Hugo S A Heymans; Eelco Dulfer; Lut Van Laer; Ian R Berry; Angus Dobbie; Ed Blair; Bart Loeys; Eric A Espiner; Jan M Wit; Wim Van Hul; Peter Houpt; Geert R Mortier
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

10.  Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.

Authors:  S M Yu; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.